Language barrier means millions of elderly can't access Alzheimer's trials

Student voices

By | Josh Eibelman , NPR

in this NPR Op-Ed, Josh Eibelman '20 describes how millions of individuals suffering from Alzheimers that are not fluent in English are barred from participating in clinical trials to treat Alzheimers. 

"According to interviews with doctors, government officials and pharmaceutical companies, few Alzheimer's studies include medical interpreters to help patients complete the specialized neuropsychological testing component required," Eibelman writes. 

Continue reading the full article on the NPR website. 

More News from A&S

three pianos on a stage
Simon Wheeler Pianist Alexander Melnikov performs on three instruments from the Cornell Center for Historical Keyboards during a 2024 concert in Barnes Hall.

Center for Historical Keyboards boosted by $5 million gift

Alumni support
A&S Communications
person standing outside

Ask an Ambassador: How research makes a difference

Undergraduate research
A&S Student Ambassador
Four people stand in a circle, chatting and smiling
Sreang Hok/Cornell University Graduate students chat at Cornell's Big Red Barn

Finding friendship at first whiff

Psychology
Cornell Chronicle
Five elephants of various sizes wade in a water hole
Ivonne Kienast/Provided "The Elephants of Dzanga Bai,” a pre-conference sound and photo installation will kick off the program on April 24

In ‘Silence’ spring conference, Fellows ‘attend to what is not there’


Society for the Humanities
A&S Communications
View all news
Students performing clinical research.